DEXERYL Trademark

Trademark Overview

On Monday, March 3, 2008, a trademark application was filed for DEXERYL with the United States Patent and Trademark Office. The USPTO has given the DEXERYL trademark a serial number of 79055616. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Sunday, May 26, 2019. This trademark is owned by PIERRE FABRE MEDICAMENT. The DEXERYL trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products for treating human skin dryness and dermatoses
dexeryl

General Information

Serial Number79055616
Word MarkDEXERYL
Filing DateMonday, March 3, 2008
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateSunday, May 26, 2019
Registration Number3570275
Registration DateTuesday, February 3, 2009
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 18, 2008

Trademark Statements

Goods and ServicesPharmaceutical products for treating human skin dryness and dermatoses
Translation of Words in MarkThe wording "DEXERYL" has no meaning in a foreign language

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, September 4, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePIERRE FABRE MEDICAMENT
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressFR
Party NamePIERRE FABRE MEDICAMENT
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressFR
Party NamePIERRE FABRE MEDICAMENT
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressFR

Trademark Events

Event DateEvent Description
Friday, December 20, 2019NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Friday, December 20, 2019DEATH OF INTERNATIONAL REGISTRATION
Friday, April 14, 2017TOTAL INVALIDATION PROCESSED BY THE IB
Friday, May 20, 2016TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Friday, May 20, 2016INVALIDATION PROCESSED
Wednesday, May 4, 2016TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, September 4, 2015CANCELLED SECTION 71
Thursday, July 2, 2009INTERNATIONAL REGISTRATION RENEWED
Thursday, June 4, 2009FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, May 13, 2009FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, May 13, 2009FINAL DISPOSITION PROCESSED
Sunday, May 3, 2009FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Friday, March 13, 2009NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, February 3, 2009REGISTERED-PRINCIPAL REGISTER
Tuesday, November 18, 2008PUBLISHED FOR OPPOSITION
Wednesday, October 29, 2008NOTICE OF PUBLICATION
Thursday, October 16, 2008LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, October 15, 2008APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, September 18, 2008TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 18, 2008CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 18, 2008ASSIGNED TO LIE
Thursday, September 11, 2008TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, September 11, 2008ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, September 11, 2008TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, September 4, 2008REFUSAL PROCESSED BY IB
Friday, August 8, 2008NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, August 8, 2008REFUSAL PROCESSED BY MPU
Friday, August 8, 2008NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, August 7, 2008NON-FINAL ACTION WRITTEN
Friday, August 1, 2008ASSIGNED TO EXAMINER
Friday, August 1, 2008NEW APPLICATION ENTERED IN TRAM
Thursday, July 31, 2008SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

Related Keywords

dexeryl dryness dermatoses skin human products treating pharmaceutical